Clinical Decision Support to Improve System Naloxone Co-prescribing

Enrolling by invitationOBSERVATIONAL
Enrollment

200,000

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

April 30, 2026

Conditions
Medication AbuseHarm ReductionOpioid OverdoseOpioid Prescribing
Interventions
OTHER

Naloxone Co-prescribing Clinical Decision Support (CDS)

Clinical decision support in the form of an EHR-integrated, provider facing alert suggesting (a) the opioid medication order is considered high risk for overdose and (b) to nudge providers to add a naloxone prescription to the opioid prescription to mitigate risk in the event of an overdose.

Trial Locations (1)

80045

University of Colorado Hospital, Aurora

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

University of Colorado, Denver

OTHER